Literature DB >> 21037360

Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement.

E K Song1, J K Seon, M S Jeong.   

Abstract

We describe a patient who developed a delayed-type hypersensitivity reaction to piperacillin/tazobactam in the cement beads and a spacer inserted at revision of total replacement of the left knee. We believe that this is the first report of such a problem. Our experience suggests that a delayed-type hypersensitivity reaction should be considered when a mixture of antibiotics such as piperacillin/tazobactam has been used in the bone cement, beads or spacer and the patient develops delayed symptoms of pain or painful paraesthesiae, fever, rash and abnormal laboratory findings in the absence of infection. The diagnosis was made when identical symptoms were induced by a provocation challenge test.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037360     DOI: 10.1302/0301-620X.92B11.24827

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  4 in total

1.  Salvage of Infected Prosthetic Breast Reconstructions.

Authors:  Amy S Xue; Katarzyna E Kania; Rodger H Brown; Jamal M Bullocks; Larry H Hollier; Shayan A Izaddoost
Journal:  Semin Plast Surg       Date:  2016-05       Impact factor: 2.314

2.  Use of antibiotic impregnated resorbable beads reduces pressure ulcer recurrence: A retrospective analysis.

Authors:  Ibrahim Khansa; Jenny C Barker; Piya Das Ghatak; Chandan K Sen; Gayle M Gordillo
Journal:  Wound Repair Regen       Date:  2018-03       Impact factor: 3.617

3.  Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy.

Authors:  Jane Cy Wong; Elaine Yl Au; Heather Hf Yeung; Chak Sing Lau; Philip Hei Li
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

4.  Identifying drug allergies by means of exposure testing - the frequency and nature of hypersensitivity reactions.

Authors:  Tobias Welponer; Matthias Brandlmaier; Bernd Feuerstein; Johann W Bauer
Journal:  Postepy Dermatol Alergol       Date:  2021-11-01       Impact factor: 1.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.